CardioBreak: All Wrong on Salt; Energy Drinks in Long QT; Gene Therapy Ups and Downs – MedPage Today
|
CardioBreak: All Wrong on Salt; Energy Drinks in Long QT; Gene Therapy Ups and Downs
MedPage Today The investigational allogeneic stem cell therapy CAP-1002 didn't look good in interim data from the phase II ALLSTAR trial, which showed futility in changing infarct size in patients suffering an MI. (BioPharmaDIVE). Angiogenic gene therapy, XC-001 … |
